Johns Hopkins Rheumatology

Home / RheumTV / Dr. Laura Cappelli on Rheumatologic Consequences of Immunotherapy to Treat Certain Cancers

Dr. Laura Cappelli on Rheumatologic Consequences of Immunotherapy to Treat Certain Cancers

By

Dr. Cappelli’s research interest involves collaboration with oncologists to study patients developing rheumatic diseases after being treated for their cancer by a new oncology drug.

Abstract Link

Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg

Dr. Cappelli’s research interest involves collaboration with oncologists to study patients developing rheumatic diseases after being treated for their cancer by a new oncology drug.
Abstract Link
Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg

Johns Hopkins Rheumatology

The Division of Rheumatology is a thriving clinical and academic center, which concentrates clinically on providing the most outstanding care to patients affected by a variety of common and uncommon rheumatic disorders.